Bioinformatics Market: Increasing Funding and Investments in Bioinformatics

In the field of genetics and genomics, bioinformatics aids in sequencing and annotating genomes. Bioinformatics plays a key role in the analysis of gene and protein expression and regulation. Bioinformatics tools aid in the comparison of genetic and genomic data and, more generally, in the understanding of evolutionary aspects of molecular biology. The role of human genomics research and related biotechnologies has the potential to achieve several public health goals, such as reducing global health inequalities by providing developing countries with efficient, cost-effective, and robust means of preventing, diagnosing, and treating major diseases that burden their populations.

Get sample PDF Copy of Bioinformatics Market study @ https://www.theinsightpartners.com/sample/TIPRE00003993?utm_source=OpenPR&utm_medium=10590

The bioinformatics market is expected to grow from US$ 12,609.39 million in 2021 to US$ 34,749.78 million by 2028; it is estimated to grow at a CAGR of 15.7% from 2022 to 2028.

Currently, cancer treatment is also set to gain from genomic information to predict how an individual responds to drugs. Private and public initiatives across multiple countries are generating and collecting human genomic data and are evolving rapidly. Since 1990, the cost of sequencing a whole genome dropped from US$ 2.7 million to as low as US$ 300, opening new opportunities to build repositories of genomic data. By the start of 2020, there were 187 genomic initiatives globally, of which 50% originated in the US and 19% in Europe. Thirty-eight million genomes were analyzed using techniques ranging from genotyping to whole genome sequencing, which is expected to grow to 52 million by 2025.

The bioinformatics market witnessed a positive impact due to increased demand for COVID-19 detection kits during the pandemic. At the biological level, SARS-CoV-2 and COVID-19 research involves high-throughput technologies, such as next-generation sequencing for detecting the genome of SARS-CoV-2, databases storing SARS-CoV-2 genomes and variants, and bioinformatics software tools and databases for analyzing and storing host-virus interactions. At the medical level, the search for therapeutic strategies, the identification of COVID-19 biomarkers, the discovery of therapeutic targets for drugs, and the bioinformatics approaches for drug repurposing, i.e., the use of already available drugs for the COVID-19 disease, were the main research themes, which further escalated the market growth. Moreover, there has been an increase in the use of synthetic gene-based technologies for studying SAR-CoV-2 virulence and facilitating vaccine development.

Agilent Technologies, Inc; Biomax Informatics Ag; Bruker Corporation; Dassault Systems; Eurofins Scientific; Geneva Bioinformatics; Illumina; Perkinelmer; Qiagen; and Thermofisher Scientific, Inc. are among the leading companies operating in the global bioinformatics market.

A few significant developments by key players in the global bioinformatics market are listed below.
In April 2022, Illumina, Inc. a global player in DNA sequencing and array-based technologies-announced the launch of its new state-of-the-art Solution Center in São Paulo, Brazil. The choice to bring the facility to Brazil reflects an increasing demand for and interest in clinical genomics, as well as Illumina's longstanding commitment to expanding global access to genomics in Latin America.

In October 2021, QIAGEN announced the completion of the move of its European Center of Excellence for Precision Medicine into facilities in Manchester's CityLabs 2.0, a new genomics campus developed with Health Innovation Manchester. The new center will anchor this world-leading genomics campus in the heart of Manchester's health-innovation district and underline the city's role as QIAGEN's global hub for diagnostics development, a crucial element of the company's global success.

Place an order copy of Bioinformatics market Research Report @ https://www.theinsightpartners.com/buy/TIPRE00003993?utm_source=OpenPR&utm_medium=10590

Contact US:
If you have any queries about this report or would like further information, please contact us:
North America: +1 646 491 9876
Asia-Pacific: +91 20 6727 8686
Email: sales@theinsightpartners.com

ABOUT US:
The Insight Partners is a one stop industry research provider of actionable solutions. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are specialist in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Our research model is very simple. We believe in client servicing and delivering best quality to our customers. Through our research content, we are making sure that our customers get value of their money along with better quality data and analysis.
Our research content is majorly focused towards market trends in terms of market sizing, competitive landscaping, company analysis, regional or country analysis etc. We provide detailed break-up of segmentation in terms of geography, technology, product and services etc.; which helps our clients to get a deeper analysis on various research topics.

This release was published on openPR.